Table 2.
Comparison of median serum level of biomarkers between infected and uninfected children.
| Median level (25th–75th percentile) | |||
|---|---|---|---|
| Biomarkers | Infected individuals n = 177 |
Healthy controls n = 22 |
p |
| IL-6 | 0.87 (0.2–3.9) | 0.39 (0.0–4.8) | 0.594 |
| sTREM | 119.00 (29.9–208.9) | 10.65 (0.0–73.4) | 0.046* |
| Eotaxin-1 | 30.15 (11.0–49.0) | 15.59 (10.8–23.3) | 0.144 |
| FABP | 315.01 (174.7–507.2) | 419.06 (382.3–559.2) | 0.201 |
| sCD23 | 2,548.60 (1,899.0–3,356.0) | 2,035.09 (1,448.0–2,939.0) | 0.050* |
| LPS | 0.26 (0.1–0.5) | 0.18 (0.0–0.5) | 0.773 |
The analysis was performed with Mann–Whitney U.
IL-6, interleukin-6; sTREM, soluble triggering receptor expressed on myeloid; FABP, fatty acid-binding protein; sCD23, soluble CD23; LPS, lipopolysaccharide.
*Significant difference at p ≤ 0.05.